MIRM

90.66

0.98% 0.88

Dopo l'orario di chiusura: 90.66

Mirum Pharmaceuticals Inc (MIRM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché MIRM Giù? Forum Previsione

Precedente Chiudi:

$89.78

Aprire:

$90.13

Volume 24 ore:

505.64K

Relative Volume:

0.61

Capitalizzazione di mercato:

$5.47B

Reddito:

$521.31M

Utile/perdita netta:

$-23.36M

Rapporto P/E:

-189.63

EPS:

-0.4781

Flusso di cassa netto:

$54.87M

1 W Prestazione:

+5.05%

1M Prestazione:

-12.07%

6M Prestazione:

+22.00%

1 anno Prestazione:

+103.46%

Intervallo 1D:

$89.74

$92.72

Intervallo di 1 settimana:

$84.33

$92.72

Portata 52W:

$36.88

$109.28

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Nome

Mirum Pharmaceuticals Inc

Settore

Healthcare (1116)

Industria

Biotechnology (621)

Telefono

650-667-4085

Indirizzo

989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY

Dipendente

372

Cinguettio

@mirumpharma

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

MIRM's Discussions on Twitter

Compare MIRM vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MIRM Mirum Pharmaceuticals Inc	90.66	5.47B	521.31M	-23.36M	54.87M	-0.4781
VRTX Vertex Pharmaceuticals Inc	469.34	119.23B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	745.77	78.84B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	700.45	43.35B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	313.41	41.57B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	284.05	31.51B	5.36B	287.73M	924.18M	2.5229

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-18	Iniziato	RBC Capital Mkts	Outperform
2025-09-24	Iniziato	TD Cowen	Buy
2025-08-11	Ripresa	Stifel	Buy
2025-05-19	Ripresa	H.C. Wainwright	Buy
2024-04-17	Iniziato	Stifel	Buy
2023-12-18	Reiterato	H.C. Wainwright	Buy
2023-11-20	Ripresa	JP Morgan	Overweight
2023-11-13	Iniziato	Morgan Stanley	Overweight
2023-10-24	Iniziato	Cantor Fitzgerald	Overweight
2023-10-17	Ripresa	Evercore ISI	Outperform
2023-09-20	Iniziato	JMP Securities	Mkt Outperform
2022-09-01	Iniziato	Citigroup	Buy
2021-09-20	Iniziato	JP Morgan	Overweight
2020-08-07	Aggiornamento	Raymond James	Outperform → Strong Buy
2020-08-03	Iniziato	H.C. Wainwright	Buy
2020-07-31	Iniziato	Piper Sandler	Overweight
2020-06-25	Iniziato	Robert W. Baird	Outperform
2019-08-12	Iniziato	Citigroup	Buy
2019-08-12	Iniziato	Evercore ISI	Outperform
2019-08-12	Iniziato	Guggenheim	Buy
2019-08-12	Iniziato	ROTH Capital	Buy
2019-08-12	Iniziato	Raymond James	Outperform

Mostra tutto

Mirum Pharmaceuticals Inc Borsa (MIRM) Ultime notizie

Mar 12, 2026

Aug Patterns: Can Mirum Pharmaceuticals Inc benefit from deglobalization2026 Catalysts & Weekly Breakout Watchlists - baoquankhu1.vn

Mar 12, 2026

How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall - simplywall.st

Mar 12, 2026

Does Advancing Brelovitug Into Late-Stage HDV Trials Change The Bull Case For Mirum Pharmaceuticals (MIRM)? - simplywall.st

Mar 12, 2026

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The AI Journal

Mar 12, 2026

Mar 11, 2026

Mirum Pharmaceuticals at Leerink Conference: Strategic Growth Plans By Investing.com - Investing.com Canada

Mar 11, 2026

Mar 10, 2026

Mirum Pharmaceuticals at Citizens Life Sciences: Strategic Pipeline Advancements By Investing.com - Investing.com Canada

Mar 10, 2026

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 10, 2026

Mar 09, 2026

Understanding the Setup: (MIRM) and Scalable Risk - Stock Traders Daily

Mar 09, 2026

Mar 07, 2026

Mirum expands into liver diseases with Bluejay Therapeutics acquisition - MSN

Mar 07, 2026

Teachers Retirement System of The State of Kentucky Invests $1.08 Million in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat

Mar 07, 2026

Mar 06, 2026